Anand MS, Varma N, Varma S, Rana KS, Malhotra P (2012) Cytogenetics and Molecular analyses in adult chronic myelogenous leukaemia patients in north India. Indian J Med Res 135:42–48

Article  PubMed  PubMed Central  Google Scholar 

Osman EA, Hamad K, Elmula IM, Ibrahim ME (2010) Frequencies of BCR-ABL1 fusion transcripts among Sudanese chronic myeloid leukaemia patients. Genet Mol Biol 33:229–231

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nowell PC (2007) Discovery of the Philadelphia chromosome: a personal perspective. J Clin Investig 117:2033–2035

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nowell PC (1960) Hungerford DA: A minute chromosome in human granulocytic leukemia (abstract). Science 132:1497

Google Scholar 

Jain P, Kantarjian H, Patel KP, Gonzalez GN, Luthra R, Shamanna RK, Pemmaraju N (2016) Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors. Blood 127(10):1269–1275

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dikshit RP, Nagrani R, Yeole B, Koyande S, Banawali S (2011) Changing trends of chronic myeloid leukemia in greater Mumbai, India over a period of 30 years. Indian J Med Paediatr Oncol 32:96–100

Article  PubMed  PubMed Central  Google Scholar 

Rowley JD (1937) A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290–293

Article  Google Scholar 

Xiaomin G, Yong Z, Jinlan P et al (2015) Chronic myeloid leukemia with e14a3 BCR ABL transcript: analysis of characteristics and prognostic significance. Leuk Lymphoma 56(12):3343–3347

Article  Google Scholar 

Mir R, Ahmad I, Javid J, Zuberi M, Yadav P, Shazia R, Saxena A (2015) Simple multiplex RT-PCR for identifying common fusion BCR-ABL transcript types and evaluation of molecular response of the a2b2 and a2b3 transcripts to Imatinib resistance in north Indian chronic myeloid leukemia patients. Indian J Cancer 52(3):314

Article  PubMed  Google Scholar 

Goldman JM, Melo JV (2008) BCR-ABL in chronic myelogenous leukemia: How does it work? Acta Haematol 119:212–217441417

Article  CAS  PubMed  Google Scholar 

Groffen J, Stephenson JR, Heisterkamp N, de Klien A, Bartram CR, Grosveld G (1984) Philadelphia chromosome breakpoints are clustered within a limited region, bcr on chromosome 22. Cell 36:93–99

Article  CAS  PubMed  Google Scholar 

Selleri L, Lindern MV, Hermans A, Meijer D, Torelli G, Grosveld G (1990) Chronic Myeloid Leukaemia may be associated with several bcr abl transcripts including the acute lymphoid leukaemia type 7 kb transcript. Blood 75:1146–1153

Article  CAS  PubMed  Google Scholar 

Pane F, Frigeri F, Sindona M, Luciano L, Ferrara F, Cimino R et al (1996) Neutrophillic chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3A2 junction). Blood 88:2410–2414

Article  CAS  PubMed  Google Scholar 

Braekeleer M (2015) BCRABL1b3a2 and b2a2 transcripts in chronic myeloid leukemia:does it matter. Eur J Haematol. https://doi.org/10.1111/ejh.12639

Article  Google Scholar 

Melo JV (1996) The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 88:2375–2384

Article  CAS  PubMed  Google Scholar 

Shepherd P, Suffolk R, Halsey J, Allan N (1995) Analysis of molecular breakpoint and m-RNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: no correlation with clinical features, cytogenetic response, duration of chronic phase, or survival. Br J Haematol 89(3):546–554

Article  CAS  PubMed  Google Scholar 

Lucas CM, Harris RJ, Giannoudis A et al (2009) Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript. Haematologica 94(10):1362–1367

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kumar L (2006) Chronic myelogenous leukemia. An update. Natl Med J India 19:255–263

PubMed  Google Scholar 

Mondal BC, Bandyopadhyaya A, Majumdar S, Mukhopadhyay A, Chandra S, Chaudhari U et al (2006) Molecular profiling of chronic myeloid leukemia in eastern India. Am J Hematol 81:845–849

Article  CAS  PubMed  Google Scholar 

Polampalli S, Choughule A, Negi N, Shinde S, Baisane S, Baisane C (2008) Analysis and comparison of clinicochematological parameters and molecular and cytogenetic response of two BCR/ABL fusion transcripts. Genet Mol Res 7:1138–1149

Article  CAS  PubMed  Google Scholar 

Sharma P, Kumar L, Mohanty S, Kochupillai V (2010) Response to imatinib mesylate in chronic myeloid leukemia patients with variant BCR-ABL fusion transcripts. Ann Hematol 89:241–247

Article  CAS  PubMed  Google Scholar 

Hasan SK, Sazawal S, Kumar B, Chaubey R, Mishra P, Mir R et al (2006) Childhood CML in India: b2a2 transcript is more common than b3a2. Cancer Genet Cytogenet 169:76–77

Article  CAS  PubMed  Google Scholar 

Zumaarraga M, Andia I, Davila R, Miller IC, Friedhoff AJ (2004) Expression in normal and in subjects with Schizophernia of a novel gene fragment originally isolated from monozygotic twins discordant for schizophrenia. Genet MolBiol 27:17–21

Google Scholar 

Muddathir A, Kordotani AA, Fadl-Elmula IM (2013) Frequency of BCR-ABL fusion transcripts in Sudanese patients with chronic myeloid leukemia using real time reverse transcription–polymerase chain reaction. Saudi Med J 34:29–33

PubMed  Google Scholar 

Shephered P, Suffolk R, Halsey J, Allan N (1995) Analysis of molecular breakpoint and m-RNA transcript in a prospective randomized trial of interferon in chronic myeloid leukemia: no-correlation with clinical features, cytogenetic response, duration of chronic phase or survival. Br J Haematol 89:546–554

Article  Google Scholar 

Adler R, Viehmann S, Kuhlisch E, Martiniak Y, Rottgers S, Harbott J et al (2009) Corelation of BCR/ABL transcript variants with patients characterstics in childhood chronic myeloid leukemia. Eur J Haematol 82:112–118

Article  PubMed  Google Scholar 

Aran Trejo RM, Ruiz Sanchez E, Ignacio-Ibarra G, Baez de la fuente E, Garces O, Gomez ME (2002) BCR/ABL P210, P190 and P230 fusion genes in 250 Mexican patients with chronic myeloid leukemia (CML). Clin Lab Haematol 24:145–150

Article  Google Scholar 

Rosas Cabral A, Martinez-Mancilla M, Ayala Sanchez M, Vela-ojeda J, Bahena-Resendiz P, Vadillo-buenfil M et al (2003) Analysis of BCR-abl type transcript and its relationship with platelet count in Mexican patients with chronic myeloid leukemia. Gac Med Mex 139:553–559

PubMed  Google Scholar 

Ruiz-arguelles GJ, Garces-Eisele J, Reyes-Nunez V, Ruiz-delgado GJ (2004) Frequencies of the breakpoint cluster region types of the BCR/ABL fusion gene in Mexican mestizo patients with chronic myelogenous leukemia. Rev Investig Clin 56:605–608

Google Scholar 

Melo JV, Gordon DE, Cross NCP, Goldman JM (1993) The ABL-BCR fusion gene is expressed in chronic myeloid leukemia. Blood 81:158–165

Article  CAS  PubMed  Google Scholar 

Khorshad JS, Lavallade H, Apperley JF, Milojkovic D, Reid AG, Bua M (2008) Finding of kinase domain mutations in patients with chronic phase chronic myeloid leukemia responding to imatinib may identify those at high risk of disease progression. J Clin Oncol 26:1–8

Google Scholar 

Vega-Ruiz A, Kantarjian H, Shan J, Weirda W, Burger J, Verstovsek S (2007) Better Molecualr response to imatinib for patients with chronic myeloid leukemia in chronic phase carrying the b3a2 transcript compared to b2a2. Blood 110(suppl.): abstract 1939

Verschragen CF, Kantarjian HM, Kantarjian C (1995) The breakpoint cluster region site in patients with Philadelphia chromosome positive chronic myelogenous leukemia clinical laboratory and prognostic co-relation. Cancer 76:992–997

Article  Google Scholar 

Neumann F, Herold C, Hildebrandt B, Kobbe G, Aivado M, Rong A, Free M, Rössig R, Fenk R, Schneider P, Gattermann N, Royer-Pokora B, Haas R, Kronenwett R (2003) Quantitative real-time reverse-transcription polymerase chain reaction for diagnosis of BCR-ABL positive leukemias and molecular monitoring following allogeneic stem cell transplantation. Eur J Haematol 70(1):1–10

Article  CAS  PubMed  Google Scholar 

Todoric-Zivanovic B, Strnad M, Stamolovic D, Tukic L, Krtolica K, Tatomirovic Z et al (2011) Frequency of BCR-ABL fusion transcript in Serbian patients with chronic myeloid leukemia. J Buon 16:14–107

Google Scholar 

Wrzesień-Kuś A, Robak T, Pluta A, Zwolińska M, Wawrzyniak E, Wierzbowska A, Pałynyczko G (2006) Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR–ABL-positive acute lymphoblastic leukemia—retrospective analysis of Polish Adult Leukemia Group (PALG). Ann Hematol 85:366–373

Article  PubMed  Google Scholar 

Millot F, Traore P, Guilhot J, Nelken B, Leblanc T, Leverger G et al (2005) Clinical and biological features at diagnosis in 40 children with chronic myeloid leukemia. Pediatrics 116:140–143

Article  PubMed  Google Scholar 

Muddathir AM, Kordofani AA, Fadl-Elmula IM (2013) Frequency of BCR-ABL fusion transcripts in Sudanese patients with chronic myeloid leukemia using real-time reverse transcription-polymerase chain reaction. Saudi Med J 34:29–33

PubMed  Google Scholar 

Arana Trejo RM, Ruiz Sanchez E, Ignacio-Ibarra G, Baez de la fuente E, Garces O, Gomez Morales E, (2002) BCR/ABL P210, P190 and P230 fusion genes in 250 Mexican patients with chronic myeloid leukemia (CML). Clin Lab Haematol 24:145–150

Article  CAS  PubMed  Google Scholar 

Paz-y-Mino C, Burgos R, Morillo SA, Santos JC, Fiallo BF, Leone PE (2002) BCR-ABL rearrangement frequencies in chronic myeloid leukemia and acute lymphoblastic leukemia in Ecuador, South America. Cancer Genet Cytogenet 132:65–67

Article  CAS  PubMed